NewEdge Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.79M Buy
35,637
+2,665
+8% +$208K 0.01% 784
2025
Q1
$2.39M Sell
32,972
-71,678
-68% -$5.2M 0.01% 781
2024
Q4
$7.75M Buy
104,650
+14,683
+16% +$1.09M 0.05% 376
2024
Q3
$5.94M Buy
89,967
+18,908
+27% +$1.25M 0.04% 424
2024
Q2
$6.56M Buy
71,059
+17,841
+34% +$1.65M 0.05% 363
2024
Q1
$5.09M Buy
53,218
+20,818
+64% +$1.99M 0.04% 387
2023
Q4
$2.46M Buy
32,400
+5,626
+21% +$428K 0.02% 594
2023
Q3
$1.85M Buy
26,774
+14,487
+118% +$1M 0.02% 622
2023
Q2
$1.16M Buy
12,287
+187
+2% +$17.6K 0.01% 797
2023
Q1
$1.02M Sell
12,100
-12,618
-51% -$1.06M 0.01% 777
2022
Q4
$489K Sell
24,718
-1,826
-7% -$36.1K 0.01% 788
2022
Q3
$2.19M Buy
26,544
+2,481
+10% +$205K 0.04% 405
2022
Q2
$2.29M Buy
24,063
+10,105
+72% +$961K 0.04% 408
2022
Q1
$1.64M Sell
13,958
-2,096
-13% -$247K 0.03% 474
2021
Q4
$2.08M Buy
16,054
+2,566
+19% +$332K 0.03% 440
2021
Q3
$1.53M Buy
13,488
+8,485
+170% +$961K 0.04% 392
2021
Q2
$518K Buy
5,003
+854
+21% +$88.4K 0.01% 729
2021
Q1
$347K Buy
+4,149
New +$347K 0.01% 760
2020
Q4
Sell
-4,156
Closed -$332K 1018
2020
Q3
$332K Sell
4,156
-1,173
-22% -$93.7K 0.01% 690
2020
Q2
$368K Sell
5,329
-8,045
-60% -$556K 0.01% 623
2020
Q1
$841K Sell
13,374
-9,147
-41% -$575K 0.04% 346
2019
Q4
$1.75M Buy
22,521
+1,155
+5% +$89.8K 0.07% 271
2019
Q3
$1.59M Buy
21,366
+11,142
+109% +$827K 0.07% 260
2019
Q2
$630K Buy
10,224
+2,592
+34% +$160K 0.04% 353
2019
Q1
$487K Buy
7,632
+873
+13% +$55.7K 0.03% 408
2018
Q4
$345 Buy
6,759
+1,506
+29% +$77 0.02% 454
2018
Q3
$305K Sell
5,253
-183
-3% -$10.6K 0.02% 488
2018
Q2
$265 Buy
5,436
+204
+4% +$10 0.02% 440
2018
Q1
$236K Buy
+5,232
New +$236K 0.03% 418
2017
Q3
Sell
-2,238
Closed -$87.7K 593
2017
Q2
$87.7K Buy
+2,238
New +$87.7K 0.02% 437